APPLICATION
ANDA078751
TYPE
ANDA
ORIGINAL APPROVAL
2010-07-07
LATEST ACTION
2015-07-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
NARATRIPTANDiscontinued
NARATRIPTAN HYDROCHLORIDE EQ 2.5MG BASE · TABLET · ORAL
NARATRIPTANDiscontinued
NARATRIPTAN HYDROCHLORIDE EQ 1MG BASE · TABLET · ORAL
Approval history
2015-07-15Labeling · Supplement 5 · standardAP
2012-04-24Labeling · Supplement 2AP
2010-12-30Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.